Unitedhealth Group Incorporated Stock Return On Asset
| UNH Stock | USD 399.92 0.76 0.19% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess UnitedHealth Group's long-term financial health and intrinsic value.
UnitedHealth | Build AI portfolio with UnitedHealth Stock |
UnitedHealth Group Incorporated Company Return On Asset Analysis
UnitedHealth Group's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current UnitedHealth Group Return On Asset | 0.0704 |
Most of UnitedHealth Group's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, UnitedHealth Group Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, UnitedHealth Group Incorporated has a Return On Asset of 0.0704. This is 100.8% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 150.29% lower than that of the firm.
UnitedHealth Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses UnitedHealth Group's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of UnitedHealth Group could also be used in its relative valuation, which is a method of valuing UnitedHealth Group by comparing valuation metrics of similar companies.UnitedHealth Group is currently under evaluation in return on asset category among its peers.
UnitedHealth Fundamentals
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0704 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 421.48 B | ||||
| Shares Outstanding | 910.22 M | ||||
| Shares Owned By Insiders | 0.24 % | ||||
| Shares Owned By Institutions | 90.66 % | ||||
| Number Of Shares Shorted | 11.58 M | ||||
| Price To Earning | 26.34 X | ||||
| Price To Book | 3.71 X | ||||
| Price To Sales | 0.89 X | ||||
| Revenue | 400.28 B | ||||
| Gross Profit | 90.17 B | ||||
| EBITDA | 9.77 B | ||||
| Net Income | 15.24 B | ||||
| Cash And Equivalents | 27.91 B | ||||
| Cash Per Share | 45.51 X | ||||
| Total Debt | 76.9 B | ||||
| Debt To Equity | 0.59 % | ||||
| Current Ratio | 0.78 X | ||||
| Book Value Per Share | 109.82 X | ||||
| Cash Flow From Operations | 24.2 B | ||||
| Short Ratio | 2.04 X | ||||
| Earnings Per Share | 23.90 X | ||||
| Price To Earnings To Growth | 0.88 X | ||||
| Target Price | 552.84 | ||||
| Number Of Employees | 400 K | ||||
| Beta | 0.62 | ||||
| Market Capitalization | 364.71 B | ||||
| Total Asset | 298.28 B | ||||
| Retained Earnings | 96.04 B | ||||
| Working Capital | (17.99 B) | ||||
| Current Asset | 31.64 B | ||||
| Current Liabilities | 42.9 B | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.35 % | ||||
| Net Asset | 298.28 B | ||||
| Last Dividend Paid | 8.4 |
About UnitedHealth Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze UnitedHealth Group Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of UnitedHealth Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of UnitedHealth Group Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out UnitedHealth Group Piotroski F Score and UnitedHealth Group Altman Z Score analysis. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.